UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 99

Sortiert nach

Recurrence and Progression of Disease in Non–Muscle-Invasive Bladder Cancer: From Epidemiology to Treatment Strategy

European urology, 2009-09, Vol.56 (3), p.430-442

2009

Link zum Volltext

Verfügbarkeit prüfen

Prospective follow‐up study of artificial urinary sphincter placement preserving the bulbospongiosus muscle

Neurourology and urodynamics, 2017-06, Vol.36 (5), p.1387-1394

2017

Link zum Volltext

Verfügbarkeit prüfen

ICUD-EAU International Consultation on Bladder Cancer 2012: Non–Muscle-Invasive Urothelial Carcinoma of the Bladder

European urology, 2013-01, Vol.63 (1), p.36-44

2013

Link zum Volltext

Verfügbarkeit prüfen

Postprostatectomy Established Stress Urinary Incontinence Treated With Duloxetine

Urology (Ridgewood, N.J.), 2011-08, Vol.78 (2), p.261-266

2011

Link zum Volltext

Verfügbarkeit prüfen

Legends in Urology V31I01

Canadian journal of urology, 2024-02, Vol.31 (1), p.11764

Narbón, Eduardo Solsona

2024

Link zum Volltext

Verfügbarkeit prüfen

Re: Final Results of an EORTC-GU Cancers Group Randomized Study of Maintenance Bacillus Calmette-Guérin in Intermediate- and High-risk Ta, T1 Papillary Carcinoma of the Urinary Bladder: One-third Dose Versus Full Dose and 1 Year Versus 3 Years of Maintenance

European urology, 2014-04, Vol.65 (4), p.847-848

Solsona, Eduardo

2014

Link zum Volltext

Verfügbarkeit prüfen

EMDA with MMC. Critical review.

Archivos españoles de urología, 2018-05, Vol.71 (4), p.409-416

Solsona, Eduardo

2018

Link zum Volltext

Verfügbarkeit prüfen

Indocyanine Green Guided Pelvic Lymph Node Dissection: An Efficient Technique to Classify the Lymph Node Status of Patients with Prostate Cancer Who Underwent Radical Prostatectomy

The Journal of urology, 2016-11, Vol.196 (5), p.1429-1435

2016

Link zum Volltext

Verfügbarkeit prüfen

Molecular and immunohistochemical analysis of the prognostic value of cell-cycle regulators in urothelial neoplasms of the bladder

European urology, 2006-09, Vol.50 (3), p.506-515

2006

Link zum Volltext

Verfügbarkeit prüfen

New Developments in the Treatment of Localized Penile Cancer

Urology (Ridgewood, N.J.), 2010-08, Vol.76 (2), p.S36-S42

2010

Link zum Volltext

Verfügbarkeit prüfen

Best approach for low-risk superficial bladder cancer

TheScientificWorld, 2006-01, Vol.6, p.2638-2645

Solsona, Eduardo

2006

Link zum Volltext

Verfügbarkeit prüfen

AdVance/AdVance XP Transobturator Male Slings: Preoperative Degree of Incontinence as Predictor of Surgical Outcome

Urology (Ridgewood, N.J.), 2013-05, Vol.81 (5), p.1034-1039

2013

Link zum Volltext

Verfügbarkeit prüfen

Re: International Phase III Trial Assessing Neoadjuvant Cisplatin, Methotrexate, and Vinblastin Chemotherapy for Muscle-Invasive Bladder Cancer: Long-Term Results of the BA06 30894 Trial

European urology, 2012-05, Vol.61 (5), p.1063-1064

Solsona, Eduardo

2012

Link zum Volltext

Verfügbarkeit prüfen

Re: Adjuvant Radiotherapy for Pathological T3N0M0 Prostate Cancer Significantly Reduces Risk of Metastasis and Improves Survival: Long-term Follow-up of a Randomized Clinical Trial

European urology, 2009-08, Vol.56 (2), p.398-399

Solsona, Eduardo

2009

Link zum Volltext

Verfügbarkeit prüfen

Predicting Nonmuscle Invasive Bladder Cancer Recurrence and Progression in Patients Treated With Bacillus Calmette-Guerin: The CUETO Scoring Model

The Journal of urology, 2009-11, Vol.182 (5), p.2195-2203

2009

Link zum Volltext

Verfügbarkeit prüfen

An Individual Patient Data Meta-Analysis of the Long-Term Outcome of Randomised Studies Comparing Intravesical Mitomycin C versus Bacillus Calmette-Guérin for Non–Muscle-Invasive Bladder Cancer

European urology, 2009-08, Vol.56 (2), p.247-256

2009

Link zum Volltext

Verfügbarkeit prüfen

Words of wisdom. Re: Final results of an EORTC-GU cancers group randomized study of maintenance bacillus Calmette-Guérin in intermediate- and high-risk Ta, T1 papillary carcinoma of the urinary bladder: one-third dose versus full dose and 1 year versus 3 years of maintenance

European urology, 2014-04, Vol.65 (4), p.847-848

Solsona, Eduardo

2014

Link zum Volltext

Verfügbarkeit prüfen

Re: Nonrandomized Comparison of Primary Chemotherapy and Retroperitoneal Lymph Node Dissection for Clinical Stage IIA and IIB Nonseminomatous Germ Cell Testicular Cancer

European urology, 2008-05, Vol.53 (5), p.1086-1088

Solsona, Eduardo

2008

Link zum Volltext

Verfügbarkeit prüfen

Re: Sequential Combination of Mitomycin C Plus Bacillus Calmette-Guerin (BCG) Is More Effective but More Toxic Than BCG Alone in Patients with Non–Muscle-Invasive Bladder Cancer in Intermediate-and High-Risk Patients: Final Outcome of CUETO 93009, A Randomized Prospective Trial

Journal of urological surgery, 2015-03, Vol.2 (1), p.40-40

2015

Link zum Volltext

Verfügbarkeit prüfen

Radical prostatectomy after radiotherapy

Archivos españoles de urología, 2012-01, Vol.65 (1), p.84

Solsona, Eduardo

2012

Link zum Volltext

Verfügbarkeit prüfen

Feasibility of Radical Transurethral Resection as Monotherapy for Selected Patients With Muscle Invasive Bladder Cancer

The Journal of urology, 2010-08, Vol.184 (2), p.475-481

2010

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 99

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(86)
Mit Volltextzugriff
(78)

Publikationsform

Artikel
(94)
Buchkapitel
(5)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(60)
Life Sciences & Biomedicine
(57)
Humans
(51)
Urology & Nephrology
(49)
Male
(39)
Urology
(36)
Middle Aged
(26)
Aged
(25)
Biological And Medical Sciences
(24)
Medical Sciences
(24)
Nephrology. Urinary Tract Diseases
(24)
Urinary Tract. Prostate Gland
(23)
Tumors Of The Urinary System
(22)
Female
(19)
Treatment Outcome
(17)
Disease Progression
(16)
Urinary Bladder Neoplasms - Pathology
(16)
Prognosis
(15)
Aged, 80 And Over
(14)
Bladder Cancer
(13)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): an open-label, phase 3, randomised controlled trial

Recurrence and Progression of Disease in Non–Muscle-Invasive Bladder Cancer: From Epidemiology to Treatment Strategy

Prospective follow‐up study of artificial urinary sphincter placement preserving the bulbospongiosus muscle

ICUD-EAU International Consultation on Bladder Cancer 2012: Non–Muscle-Invasive Urothelial Carcinoma of the Bladder

Postprostatectomy Established Stress Urinary Incontinence Treated With Duloxetine

Legends in Urology V31I01

Re: Final Results of an EORTC-GU Cancers Group Randomized Study of Maintenance Bacillus Calmette-Guérin in Intermediate- and High-risk Ta, T1 Papillary Carcinoma of the Urinary Bladder: One-third Dose Versus Full Dose and 1 Year Versus 3 Years of Maintenance

EMDA with MMC. Critical review.

Indocyanine Green Guided Pelvic Lymph Node Dissection: An Efficient Technique to Classify the Lymph Node Status of Patients with Prostate Cancer Who Underwent Radical Prostatectomy

Molecular and immunohistochemical analysis of the prognostic value of cell-cycle regulators in urothelial neoplasms of the bladder

New Developments in the Treatment of Localized Penile Cancer

Best approach for low-risk superficial bladder cancer

AdVance/AdVance XP Transobturator Male Slings: Preoperative Degree of Incontinence as Predictor of Surgical Outcome

Re: International Phase III Trial Assessing Neoadjuvant Cisplatin, Methotrexate, and Vinblastin Chemotherapy for Muscle-Invasive Bladder Cancer: Long-Term Results of the BA06 30894 Trial

Re: Adjuvant Radiotherapy for Pathological T3N0M0 Prostate Cancer Significantly Reduces Risk of Metastasis and Improves Survival: Long-term Follow-up of a Randomized Clinical Trial

Predicting Nonmuscle Invasive Bladder Cancer Recurrence and Progression in Patients Treated With Bacillus Calmette-Guerin: The CUETO Scoring Model

An Individual Patient Data Meta-Analysis of the Long-Term Outcome of Randomised Studies Comparing Intravesical Mitomycin C versus Bacillus Calmette-Guérin for Non–Muscle-Invasive Bladder Cancer

HAS A 3-FOLD DECREASED DOSE OF BACILLUS CALMETTE-GUERIN THE SAME EFFICACY AGAINST RECURRENCES AND PROGRESSION OF T1G3 AND TIS BLADDER TUMORS THAN THE STANDARD DOSE? RESULTS OF A PROSPECTIVE RANDOMIZED TRIAL

Words of wisdom. Re: Final results of an EORTC-GU cancers group randomized study of maintenance bacillus Calmette-Guérin in intermediate- and high-risk Ta, T1 papillary carcinoma of the urinary bladder: one-third dose versus full dose and 1 year versus 3 years of maintenance

Re: Nonrandomized Comparison of Primary Chemotherapy and Retroperitoneal Lymph Node Dissection for Clinical Stage IIA and IIB Nonseminomatous Germ Cell Testicular Cancer

Re: Sequential Combination of Mitomycin C Plus Bacillus Calmette-Guerin (BCG) Is More Effective but More Toxic Than BCG Alone in Patients with Non–Muscle-Invasive Bladder Cancer in Intermediate-and High-Risk Patients: Final Outcome of CUETO 93009, A Randomized Prospective Trial

Radical prostatectomy after radiotherapy

The EORTC Tables Overestimate the Risk of Recurrence and Progression in Patients with Non–Muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin: External Validation of the EORTC Risk Tables

Feasibility of Radical Transurethral Resection as Monotherapy for Selected Patients With Muscle Invasive Bladder Cancer

Suchergebnisse filtern